Another Biogen Alzheimer’s drug expedited by the FDA

Just weeks after winning approval from the U.S. Food and Drug Administration for its Alzheimer’s drug Aduhelm — a decision that continues to be mired in controversy — Biogen Inc. (Nasdaq: BIIB) has scored breakthrough therapy designation for another, similar drug called lecanemab. Read More

Read More

Baker proposes two-month sales tax holiday starting in August

The proposal would dramatically expand this year’s sales day holiday, which typically lasts a single weekend. The state can afford the loss of revenue, and the measure would help consumers and small businesses recover from the pandemic, the governor said. Read More

Read More

Op-ed: Strengthening the human infrastructure of our care economy

The CEO of Rogerson Communities writes in this exclusive BBJ op-ed: "As a community, we cannot let our seniors down. We must invest in services that provide access to quality, affordable in-home or community-based care for aging relatives and people with disabilities." Read More

Read More

Fintech for car loans raises $360M to fuel expansion, Boston hires

Lendbuzz, based at 100 Summer St. next to Boston’s South Station, provides car loans to people who don’t have a U.S. credit history or FICO score, and makes money by charging customers with interests on loans. A machine learning platform evaluates applicants based on their employment history and their educational background. Approved applicants can either…

Read More

Third Rock launches new cell therapy startup

Third Rock has launched a new cell-therapy startup looking to use T regulatory cells to combat autoimmune diseases like MS and diabetes — and it’s got $95M and a partnership with ElevateBio to help get it going. Read More

Read More